United Kingdom

Converging technologies are changing the face of healthcare. What is the role of industry in driving this change, and how can the public and private sectors work together?

Two of the UK’s publicly funded nanotechtechnology promotion bodies have joined forces to speed the development of applications in regenerative medicine, diagnostics, imaging and drug discovery.